Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

iCAD, Inc. (ICAD 1.46, -0.04, -2.67%) , an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, congratulates its partner, Accuray , in receiving a 2010 Minnie Award for the CyberKnife(R) VSI(TM) System.

The Minnie Awards are an annual event produced by AuntMinnie.com, a highly-regarded news and research outlet for radiologists and related professionals in the medical imaging industry.

The CyberKnife VSI System extends the CyberKnife System's world-class, robotic radiosurgery capabilities to enable high precision radiation therapy and Robotic IMRT(TM). The CyberKnife System is a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body where radiation is indicated, and is frequently used to treat patients with early-stage prostate cancer.

"We are pleased to congratulate Accuray for its Minnie Award," said Rick Ortega, Director of MRI Programs at iCAD. "iCAD has worked closely with Accuray to help physicians better diagnose and treat prostate cancer, which can be a challenge because of the vascularity and its location deep within the abdominal/pelvic cavity. This award recognizes Accuray for its technological breakthrough in delivering potentially lifesaving radiation therapy, non-invasively, for cancer patients."

iCAD will be hosting several mini educational sessions at its booth, #6216, at the RSNA-2010 meeting, being held in Chicago from November 28 to December 3, 2010. One of the sessions, "Treatment Planning with the CyberKnife (R) Robotic Radiosurgery System and Quantitative Image Analysis," will provide insight on how DCE MRI with iCAD 's quantitative image analysis solution, VividLook(R), can improve the sensitivity and specificity of prostate cancer localization, detection and improved treatment planning for patients undergoing CyberKnife therapy. These sessions are scheduled for:

Monday, November 29, from 2:30 to 2:45 PM Tuesday, November 30, from 4:30 to 4:45 PM

More information on the educational sessions can be found at www.icadmed.com/newsevents/RSNA2010.htm.

"The CyberKnife radiosurgical planning and delivery system can be used to create an extremely customized radiation dose distribution tailored to focus the highest regions of dose on the most heavily cancer involved areas within the prostate and deliver this dose pattern with sub-millimeter accuracy and precision," said Donald B. Fuller, M.D., radiation oncologist, the CyberKnife Centers of San Diego and Radiation Medical Group. "The iCAD VividLook technology represents an innovative next-generation imaging method for mapping these tumor-bearing regions, exceeding the capability of existing diagnostic techniques. The direct three-dimensional computerized integration of these complementary technologies shows great promise in delivering a quantum leap forward in the customization of every treatment plan, to most exactly and safely treat the specific cancer involvement pattern of each individual prostate cancer patient."

Source: iCAD, Inc.